查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2047047

振盪式正壓呼吸治療市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年

Oscillatory Positive Expiratory Pressure Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 177 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球振盪式正壓通氣（OPEP）市場預計將從 2025 年的 28.9 億美元成長到 2031 年的 42.8 億美元，複合年成長率為 6.76%。

呼氣幫浦（OPP）設備是一種非侵入性醫療解決方案，旨在透過呼氣時的​​阻力和振動來幫助排放黏液，從而有效鬆動支氣管分泌物。此市場成長的主要促進因素是全球慢性呼吸系統疾病（如囊腫纖維化、支氣管擴張和慢性阻塞性肺病（COPD））盛行率的不斷上升，以及老年人口的成長（老年人更容易出現肺功能下降）。這些因素使得該市場的發展區別於短期市場波動，並代表了在家庭環境中進行疾病管理和預防呼吸系統併發症的長期醫療需求。

市場概覽
預測期 2027-2031
市場規模：2025年 28.9億美元
市場規模：2031年 42.8億美元
複合年成長率：2026-2031年 6.76%
成長最快的細分市場 氣喘
最大的市場 北美洲

然而，市場擴張的一大障礙是各地區保險覆蓋範圍不統一，這限制了患者獲得這些關鍵治療的機會。鑑於需要有效清除呼吸道疾病的患者數量龐大，此經濟障礙尤為嚴重。世界衛生組織（世衛組織）報告稱，到2025年，僅在世衛組織歐洲區域，就有8,170萬人將患有慢性呼吸系統疾病，這凸顯了口腔護理設備製造商在複雜的監管和經濟環境下必須應對的巨大負擔。

市場促進因素

慢性阻塞性肺病（COPD）和氣喘在全球範圍內的日益流行，是全球振盪式正壓通氣（OPEP）市場的主要促進因素，也因此對有效清除氣道痰液的需求持續成長。由於這些呼吸系統疾病具有慢性特徵，定期清除痰液對於預防病情嚴重加重和住院至關重要。 2025年5月，美國疾病管制與預防中心（CDC）報告稱，2023年美國成年人經年齡調整後的COPD確診為3.8%。環境風險因素會加速肺功能下降，進一步加重了這個臨床負擔。 2025年4月，美國肺臟協會指出，1.561億美國人生活在空氣污染程度不健康的地區，增加了容易有呼吸系統疾病且需要非藥物治療的人。

第二個關鍵因素是攜帶式、不受重力影響的OEP設備的設計技術進步。與傳統物理治療相比，這些設備顯著提高了患者的治療依從性。現代OEP設備體積小巧，可在任何體位下使用，並增強了患者在治療過程中的活動能力。這對於其在居家照護中的應用至關重要。這種以用戶為中心的設計理念正在改變市場競爭格局，製造商正致力於提升產品的有效性和易用性以贏得市場佔有率。莫納漢醫療公司在2025年12月榮獲AARC Zenith獎，這是該公司11年來第十次獲此殊榮，也凸顯了可靠且創新的呼吸技術的重要性，這充分證明了該行業在滿足這些標準方面的成功。這些創新透過推廣高品質的設備，並使患者能夠在臨床環境之外獲得持續治療，從而推動了市場成長。

市場挑戰

不同地區保險覆蓋範圍的差異對全球振動式正壓通氣（OPEP）市場的擴張構成了重大的經濟障礙。儘管OPEP設備在清除氣道阻塞方面發揮至關重要的作用，但醫療政策的差異往往導致患者自付費用高昂，從而顯著降低了設備的普及率。這種經濟負擔對老年人和長期患病但收入穩定的患者等關鍵使用者群體的影響尤其嚴重。因此，當患者因保險覆蓋不足而無法獲得這些必要的治療時，市場難以將高臨床需求轉化為永續的收入成長。

患者需求與購買力之間的差距限制了該行業有效觸及所有潛在市場的能力。近期流行病學數據凸顯了這個未被滿足的需求的規模。根據美國肺臟協會統計，到2025年，美國將有超過3500萬人患有慢性肺病。這項統計數據表明，儘管需要持續呼吸支持的患者群體龐大，但獲得光學輔助肺動脈高壓（OEP）治療的機會可能有限，從而限制了市場成長，即便疾病患病率處於有利水平。

市場趨勢

正壓通氣（OPEP）合併霧化療法正逐漸成為重要的治療趨勢，旨在減輕慢性呼吸系統疾病患者繁重的日常治療負擔。這種綜合療法能夠同時清除黏液並輸送氣溶膠藥物，從而顯著縮短整體治療時間。這對於提高患者的用藥依從性至關重要。近期的一些性能數據也支持了這種雙模式療法的技術可行性。 Trudell Medical International 於 2024 年 6 月進行的一項實驗室研究（詳見其報告《正壓通氣聯合霧化療法：聚焦粘液清除》）表明，聯合治療能夠在保持與單獨使用正壓通氣療法相當的治療時間的同時，將超過 80% 的藥物輸送到可吸入的液滴大小範圍內。這種高效性使得在不犧牲振盪壓力機械優勢的前提下，實現有效的藥物干預，從而推動市場向多功能設備生態系統發展。

同時，將智慧數位連接功能整合到呼吸器中，用於追蹤患者的用藥依從性，正將機械設備轉變為互聯的呼吸健康平台，重塑市場競爭格局。製造商日益關注能夠監測使用模式並提供即時回饋的數位治療方法，以應對居家照護環境中用藥依從性差這一普遍挑戰。這種數據主導的轉變得益於互聯護理帶來的臨床療效提升。 Health Tech World 在 2025 年 2 月報告稱，使用呼吸數位護理方案四個月或以上的患者，其健康評分提高了 41%。如此顯著的改善凸顯了將互聯功能融入 OEP 策略的日益成長的市場價值，從而確保可衡量的長期治療效果。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球振盪式正壓呼吸器市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（面罩式 OEP 設備、口含式 OEP 設備、瓶式 OEP 設備）
    • 用途（氣喘、肺塌陷、支氣管炎等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美振盪式正壓呼吸器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲振盪式正壓呼吸療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區振盪式正壓呼吸器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲振盪式正壓呼吸療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲振盪式正壓呼吸療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球振盪式正壓呼吸器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Monaghan Medical Corporation
  • Hill-Rom Holdings, Inc.
  • ICU Medical, Inc.
  • Respironics, Inc.
  • Teleflex Incorporated
  • GlaxoSmithKline plc
  • Telecare Services, Inc.
  • Summit Medical Products, Inc.
  • Fisher & Paykel Healthcare Corporation Limited

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 16781

The Global Oscillatory Positive Expiratory Pressure (OPEP) Market is projected to expand from USD 2.89 Billion in 2025 to USD 4.28 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 6.76%. OPEP devices are non-invasive medical solutions designed to aid mucus clearance through resistance and vibrations during exhalation, effectively loosening bronchial secretions. This market growth is primarily fueled by the increasing worldwide incidence of chronic respiratory conditions like cystic fibrosis, bronchiectasis, and Chronic Obstructive Pulmonary Disease (COPD), along with a growing elderly population prone to declining lung function. These factors represent a fundamental, long-term healthcare need for managing diseases and preventing respiratory complications in home settings, distinct from short-term market fluctuations.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.89 Billion
Market Size 2031USD 4.28 Billion
CAGR 2026-20316.76%
Fastest Growing SegmentAsthma
Largest MarketNorth America

However, a significant obstacle to market expansion is the inconsistent reimbursement coverage across various regions, which limits patient access to these crucial therapies. This financial hurdle is particularly problematic given the vast number of patients requiring effective airway clearance. The World Health Organization reported that in 2025, 81.7 million people in the WHO European Region alone were affected by chronic respiratory diseases, highlighting the substantial burden OPEP manufacturers must address amidst complex regulatory and financial environments.

Market Driver

The escalating global prevalence of Chronic Obstructive Pulmonary Disease (COPD) and asthma is the primary driver for the Global Oscillatory Positive Expiratory Pressure Market, creating a consistent need for effective airway clearance. The chronic nature of these respiratory illnesses necessitates regular mucus mobilization to prevent severe flare-ups and hospitalizations. The Centers for Disease Control and Prevention reported in May 2025 that the age-adjusted prevalence of diagnosed COPD in adults in the U.S. was 3.8% in 2023. This clinical burden is exacerbated by environmental hazards that accelerate lung function decline; the American Lung Association noted in April 2025 that 156.1 million Americans lived in areas with unhealthy air pollution levels, thereby increasing the population susceptible to respiratory issues requiring non-pharmacological interventions.

A second significant driver is technological advancements in portable and gravity-independent OPEP device designs, which notably improve patient adherence compared to traditional physiotherapy. Modern OPEP devices are now compact and operable in any position, allowing patients greater mobility during therapy-a key factor for widespread home-care adoption. This emphasis on user-centric design is transforming market competition, with manufacturers focusing on efficacy and ease of use to gain market share. The industry's success in meeting these standards is evidenced by Monaghan Medical Corporation's 10th win in 11 years of the '2025 AARC Zenith Award' in December 2025, highlighting the critical importance of reliable, innovative respiratory technologies. Such innovations distinguish premium devices, fostering market growth by ensuring consistent therapy outside clinical settings.

Market Challenge

Inconsistent reimbursement coverage across different regions poses a significant economic impediment to the Global Oscillatory Positive Expiratory Pressure Market's expansion. Despite the essential role of OPEP devices in airway clearance, varied healthcare policies frequently lead to substantial out-of-pocket costs for patients, severely reducing device adoption rates. This financial strain is especially impactful for the primary user base, which often includes elderly individuals or those managing lifelong conditions on fixed incomes. As a result, when patients cannot afford these vital therapies due to coverage gaps, the market struggles to translate high clinical demand into sustainable revenue growth.

This disparity between patient need and purchasing capability restricts the industry's ability to effectively reach its entire potential market. The magnitude of this unmet need is underscored by recent prevalence data: the American Lung Association reported that in 2025, over 35 million people in America were living with chronic lung disease. This statistic highlights the vast patient population requiring ongoing respiratory support, yet potentially facing limited access to OPEP therapy, thereby constraining the market's growth trajectory despite favorable disease prevalence.

Market Trends

The adoption of combined OPEP and nebulizer therapies is emerging as a crucial trend aimed at reducing the substantial daily treatment burden for patients with chronic respiratory conditions. This integrated approach allows for simultaneous mucus clearance and aerosol medication delivery, significantly cutting down on overall therapy time-a vital factor for promoting consistent patient compliance. The technical feasibility of this dual-modality treatment is supported by recent performance data; a June 2024 laboratory study by Trudell Medical International, detailed in their 'Combination Therapy (OPEP and Nebulizer) to Provide Focus to Mucus Clearance' report, showed that combined therapy delivered over 80% of medication in the respirable droplet size range while maintaining a treatment duration similar to OPEP therapy alone. This efficiency ensures effective pharmacological intervention without sacrificing the mechanical benefits of oscillatory pressure, thereby propelling the market towards multi-functional device ecosystems.

Concurrently, the integration of smart digital connectivity for adherence tracking is redefining the competitive landscape by transforming mechanical devices into connected respiratory health platforms. Manufacturers are increasingly focusing on digital therapeutics that monitor usage patterns and offer real-time feedback to tackle the widespread issue of non-adherence in home-care environments. This data-driven shift is validated by improved clinical outcomes linked to connected care; Health Tech World reported in February 2025 that patients using a respiratory digital care plan for four months or longer experienced a 41% increase in their wellness scores. Such significant improvements underscore the growing market value of embedding connectivity into OPEP strategies to ensure measurable, long-term therapeutic success.

Key Market Players

  • Monaghan Medical Corporation
  • Hill-Rom Holdings, Inc.
  • ICU Medical, Inc.
  • Respironics, Inc.
  • Teleflex Incorporated
  • GlaxoSmithKline plc
  • Telecare Services, Inc.
  • Summit Medical Products, Inc.
  • Fisher & Paykel Healthcare Corporation Limited

Report Scope

In this report, the Global Oscillatory Positive Expiratory Pressure Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oscillatory Positive Expiratory Pressure Market, By Type

  • Facemask OPEP Devices
  • Mouthpiece OPEP Devices
  • Bottle OPEP Devices

Oscillatory Positive Expiratory Pressure Market, By Application

  • Asthma
  • Atelectasis
  • Bronchitis
  • Other

Oscillatory Positive Expiratory Pressure Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oscillatory Positive Expiratory Pressure Market.

Available Customizations:

Global Oscillatory Positive Expiratory Pressure Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oscillatory Positive Expiratory Pressure Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Facemask OPEP Devices, Mouthpiece OPEP Devices, Bottle OPEP Devices)
    • 5.2.2. By Application (Asthma, Atelectasis, Bronchitis, Other)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Oscillatory Positive Expiratory Pressure Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oscillatory Positive Expiratory Pressure Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Oscillatory Positive Expiratory Pressure Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Oscillatory Positive Expiratory Pressure Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Oscillatory Positive Expiratory Pressure Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Oscillatory Positive Expiratory Pressure Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Oscillatory Positive Expiratory Pressure Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Oscillatory Positive Expiratory Pressure Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Oscillatory Positive Expiratory Pressure Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Oscillatory Positive Expiratory Pressure Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Oscillatory Positive Expiratory Pressure Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Oscillatory Positive Expiratory Pressure Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Oscillatory Positive Expiratory Pressure Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Oscillatory Positive Expiratory Pressure Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Oscillatory Positive Expiratory Pressure Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Oscillatory Positive Expiratory Pressure Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Oscillatory Positive Expiratory Pressure Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Oscillatory Positive Expiratory Pressure Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Oscillatory Positive Expiratory Pressure Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Oscillatory Positive Expiratory Pressure Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Oscillatory Positive Expiratory Pressure Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Oscillatory Positive Expiratory Pressure Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Oscillatory Positive Expiratory Pressure Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Oscillatory Positive Expiratory Pressure Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Oscillatory Positive Expiratory Pressure Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Monaghan Medical Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Hill-Rom Holdings, Inc.
  • 15.3. ICU Medical, Inc.
  • 15.4. Respironics, Inc.
  • 15.5. Teleflex Incorporated
  • 15.6. GlaxoSmithKline plc
  • 15.7. Telecare Services, Inc.
  • 15.8. Summit Medical Products, Inc.
  • 15.9. Fisher & Paykel Healthcare Corporation Limited

16. Strategic Recommendations

17. About Us & Disclaimer